Additionally, antibody blockade of PD-1 or its ligands restored IgM secretion in TCDD-treated CD5+ B cells suggesting, for the first time, a direct role for PD-1 in TCDD-mediated immunotoxicity. Here, CD5 is linked to immune system toxicity.